Amiodarone induced pulmonary toxicity.
Amiodaronem indukované postižení plic u pacienta s fibrilací síní.
AIPT
amiodarone
amiodarone induced pulmonary toxicity
amiodarone lung
Journal
Vnitrni lekarstvi
ISSN: 0042-773X
Titre abrégé: Vnitr Lek
Pays: Czech Republic
ID NLM: 0413602
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
23
4
2022
pubmed:
1
1
2021
medline:
27
4
2022
Statut:
ppublish
Résumé
Amiodarone is one of the more frequently used drugs in the treatment of supraventricular and ventricular arrhythmias. Many adverse effects, more or less serious, are associated with its administration. Amiodaron-induced pulmonary toxicity (AIPT) is quite rare but represents one of the most severe adverse effects with high mortality. We present an 80 years old patient, who used amidorane due to paroxysmal atrial fibrillation for several years. Within 3 months, he was repeatedly hospitalized for a bilateral pneumonia. Eventually, AIPT was diagnosed. Early diagnosis, proper therapy of AIPT and changed antiarrhythmic therapy has significantly improved the clinical status of our patient. In this case we demonstrate typical clinical presentations of AIPT as well as the most common diagnostic procedures and recommended treatment methods. Finally, some other commonly used therapeutical options for supraventricular arrhythmias are mentioned. Future options are outlined.
Substances chimiques
Anti-Arrhythmia Agents
0
Amiodarone
N3RQ532IUT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM